Affiliations 

  • 1 National Heart Centre Singapore
  • 2 St. Vincent's Hospital Sydney, Australia
  • 3 St. Vincent's Private Hospital Northside Chermside, Australia
  • 4 Vanderbilt University Medical Center Nashville, TN, US
  • 5 Queen Elizabeth Hospital Hong Kong
  • 6 Apollo Hospitals Chennai, India
  • 7 Medistra Hospital Jakarta, Indonesia
  • 8 Kurashiki Central Hospital Kurashiki, Japan
  • 9 CVSKL Hospital Kuala Lumpur, Malaysia
  • 10 National University Heart Centre Singapore
  • 11 Ramathibodi Hospital Mahidol University Bangkok, Thailand
  • 12 Taipei Veterans General Hospital Taipei, Taiwan
  • 13 Department of Cardiology, Hanoi Medical University, Vietnam National Heart Institute Hanoi, Vietnam
  • 14 Fuwai Hospital CAMS & PUMC, National Center for Cardiovascular Diseases Beijing, China
  • 15 National Cerebral and Cardiovascular Center Suita, Japan
  • 16 St Marianna University School of Medicine Kawasaki, Japan
  • 17 Keio University School of Medicine Tokyo, Japan
  • 18 Yonsei University Seoul, Korea
  • 19 Asan Medical Center Seoul, Korea
  • 20 Icahn School of Medicine at Mount Sinai New York, US
  • 21 Sendai Kousei Hospital Sendai, Japan
Eur Cardiol, 2021 Feb;16:e25.
PMID: 34163538 DOI: 10.15420/ecr.2021.01

Abstract

Transcatheter mitral valve repair with the MitraClip, a catheter-based percutaneous edge-to-edge repair technique to correct mitral regurgitation (MR), has been demonstrated in Western studies to be an effective and safe MR treatment strategy. However, randomised clinical trial data on its use in Asian-Pacific patients is limited. Hence, the Asian Pacific Society of Cardiology convened an expert panel to review the available literature on MitraClip and to develop consensus recommendations to guide clinicians in the region. The panel developed statements on the use of MitraClip for the management of degenerative MR, functional MR, and other less common indications, such as acute MR, dynamic MR, hypertrophic obstructive cardiomyopathy, and MR after failed surgical repair. Each statement was voted on by each panel member and consensus was reached when 80% of experts voted 'agree' or 'neutral'. This consensus-building process resulted in 10 consensus recommendations to guide general cardiologists in the evaluation and management of patients in whom MitraClip treatment is being contemplated.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.